# Dapsone 25 mg

NDC: 83098-102
Generic name: Dapsone Tablets
Labeler / Manufacturer: Everest Life Sciences. LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20240901

FDA application: ANDA086841

## Active ingredients

- DAPSONE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83098-102"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83098-102
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1d026bb6-05da-e9cf-e063-6394a90a2485